Sign in
Taking people in United StatesNo phase

External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients

Key facts

Who runs it
University of Pennsylvania
Where
Philadelphia, United StatesSee the site
Trial code
Status
Recruiting
People taking part
10 people, planned
Started
4 Jan 2026
Expected to end
1 Jul 2028
Type of study
Interventional
Treatments tested
  • Thoracic duct drainage
Record updated
18 February 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • Adult (18-80 years) patients in Surgical ICU with suspected or documented infection on antibiotics and septic shock defined as hypotension requiring vasopressor therapy to maintain MAP > 65mmHg (modified from Sepsis-35); Participants will fulfill the inclusion criteria not only at recruitment and consent, but also be confirmed to still meet those criteria immediately prior to transfer to IR for the procedure; The patient will not be recruited if he or she no longer meet these criteria; Patients experiencing hemodynamic instability, defined as (1) MAPs < 65 despite ongoing up-titration of pressors and volume resuscitation or (2) active titration of vasopressors (more than 2 increases in past hour) or active volume resuscitation (more than 1-liter bolus in past hour) that precludes travel to IR during the intervention window will be excluded from the study and considered screen fails

Who cannot take part

  • Prior instrumentation of the lymphatic system
  • Previous left axillary node dissection ± left upper limb lymphoedema
  • Immunocompromised state (active cytotoxic chemotherapy or transplant recipient)
  • Subject or authorized representative not willing to provide consent (unconscious patient will need to countersign prior to analysis of samples)
  • Class 4 heart failure
  • Any chronic medical condition for which the patient is expected to have <6-month survival
  • Decompensated liver failure with ascites
  • Portal hypertension with history of variceal bleeding
  • Severe allergy to contrast agents
  • Uncorrectable coagulopathy or INR >1.5
  • Uncorrectable thrombocytopenia (platelet count less than 50,000)
  • Open abdomen
  • Intra-abdominal sepsis preventing access to the lymphatic system
  • Known occlusion of the left subclavian vein
  • Known malformation of the lymphatic system
  • Need for continuous anticoagulation (that cannot be stopped for procedure)
  • Pregnancy
  • DNR ('do not resuscitate') status
  • Unable to have central venous line or arterial line in place

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

This trial is currently available in United States.

  • Hospital of the University of PennsylvaniaPhiladelphia, United StatesContact: Niels D Martin, MDTaking people

About the trial

What the trial wants to find out

To demonstrate that external drainage of thoracic duct lymph during sepsis results in a reduction in circulating pro-inflammatory cytokines.

Read full original descriptionShow less

To demonstrate safety and feasibility of early thoracic duct cannulation and external lymph drainage for up to 7 days in adult surgical intensive care patients.

To explore other biochemical and physiological endpoints that can be used for the design of future randomized controlled trials and estimate effect size of external drainage.

The group in the trial

  • Thoracic Duct DrainageTreatment being tested

    This is the main study group of patients with thoracic duct drainage

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients: A Pilot Trial With Concurrent Controls to Confirm Safety and Assess Preliminary Efficacy
Criteria questions
Built from NCT04855786, who can take part
Record updated
18 February 2026